Quick Answer
QIAGEN N.V. reported Total Revenue of $2.09 billion for fiscal year 2025.
QIAGEN N.V. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $2.09B | +5.7% |
| 2024 | $1.98B | +0.7% |
| 2023 | $1.97B | -8.2% |
| 2022 | $2.14B | -4.9% |
| 2021 | $2.25B | +20.4% |
| 2020 | $1.87B | +22.5% |
| 2019 | $1.53B | +1.6% |
| 2018 | $1.50B | +5.9% |
| 2017 | $1.42B | +5.9% |
| 2016 | $1.34B | +4.5% |
| 2015 | $1.28B | -4.7% |
| 2014 | $1.34B | +3.3% |
| 2013 | $1.30B | +3.8% |
| 2012 | $1.25B | +7.2% |
| 2011 | $1.17B | +7.6% |
| 2010 | $1.09B | +7.7% |
| 2009 | $1.01B | +13.1% |
| 2008 | $892.98M | — |
- QIAGEN N.V. showed an increase of +5.7% in Total Revenue compared to the prior fiscal year.
- Over the 2008–2025 period, QIAGEN N.V.’s total revenue has grown by 134.0% (from $892.98 million to $2.09 billion).
- The most recent figure is from QIAGEN N.V.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: